Technical Analysis for BIOC - Biocept, Inc.

Grade Last Price % Change Price Change
C 5.9378 -3.61% -0.22
BIOC closed down 4.64 percent on Tuesday, March 2, 2021, on approximately normal volume.
Earnings due: Mar 23
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical BIOC trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -3.61%
Outside Day Range Expansion -3.61%
Wide Bands Range Expansion -3.61%
Oversold Stochastic Weakness -3.61%
Wide Bands Range Expansion -8.08%
Oversold Stochastic Weakness -8.08%
200 DMA Support Bullish -1.53%
50 DMA Support Bullish -1.53%
Stochastic Reached Oversold Weakness -1.53%
Wide Bands Range Expansion -1.53%
Older End-of-Day Signals for BIOC ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
50 DMA Support about 2 hours ago
Down 5% about 2 hours ago
60 Minute Opening Range Breakdown about 2 hours ago
Down 3% about 2 hours ago
Down 2 % about 2 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Biocept, Inc., a cancer diagnostics company, is engaged in the development and commercialization of proprietary circulating tumor cell (CTC) and circulating tumor DNA tests. The company's tests provide information to oncologists that enable them to select the appropriate treatment for their patients based on detailed data on the characteristics of tumors. Its tests include OncoCEE-BR, a breast cancer CTC test that allows physician to characterize the tumor to help define treatment options. The company sells its products through its sales force and partners that focus on selling directly to community oncologists in hospitals, cancer centers, and offices in the United States. Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Cancer Clinical Medicine Oncology Breast Cancer Treatment Of Breast Cancer Tumor Tumors Anatomical Pathology Cancer Center Tumor Cell Foundation Medicine

Is BIOC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.0
52 Week Low 2.112
Average Volume 550,126
200-Day Moving Average 5.83
50-Day Moving Average 5.99
20-Day Moving Average 6.91
10-Day Moving Average 6.72
Average True Range 0.61
ADX 28.2
+DI 24.17
-DI 24.97
Chandelier Exit (Long, 3 ATRs ) 6.54
Chandelier Exit (Short, 3 ATRs ) 7.48
Upper Bollinger Band 8.02
Lower Bollinger Band 5.79
Percent B (%b) 0.17
BandWidth 32.30
MACD Line 0.07
MACD Signal Line 0.26
MACD Histogram -0.1909
Fundamentals Value
Market Cap 82.52 Million
Num Shares 13.4 Million
EPS -2.63
Price-to-Earnings (P/E) Ratio -2.34
Price-to-Sales 5.12
Price-to-Book 3.21
PEG Ratio -0.04
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.56
Resistance 3 (R3) 7.68 7.33 7.32
Resistance 2 (R2) 7.33 6.98 7.27 7.24
Resistance 1 (R1) 6.75 6.76 6.58 6.63 7.17
Pivot Point 6.40 6.40 6.32 6.34 6.40
Support 1 (S1) 5.82 6.05 5.65 5.70 5.15
Support 2 (S2) 5.47 5.83 5.41 5.08
Support 3 (S3) 4.89 5.47 5.00
Support 4 (S4) 4.77